Laboratory and Plaque - Cardiovascular Update

Impact of Deucravacitinib on Plaque Psoriasis Treatment Landscape

HCPLive

MARCH 20, 2024

An expert in dermatologic conditions examines laboratory requirements for initiating deucravacitinib in patients with moderate-to-severe plaque psoriasis and the impact of deucravacitinib on the treatment landscape.

Plaque

Plaque Laboratory

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

We investigated whether treatment with LDE-paclitaxel changes plaque progression by coronary CT angiography and is safe in patients with chronic coronary artery disease. Clinical and laboratory safety evaluations were made at baseline and every 3 weeks until the end of the study.

Coronary Artery Disease

Coronary Artery Disease Laboratory Plaque Myocardial Infarction

Roche's Lp(a) Gen.2 Molarity Assay Receives FDA Clearance

DAIC

FEBRUARY 3, 2025

By using molar units, laboratory professionals and clinicians know the Lp(a) measurements reflect the number of particles rather than any difference in the size of the particles. "We

Cardiovascular Disease

Cardiovascular Disease Aortic valve Biomarkers Innovation

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Coronary Artery Calcification: Current Concepts and Clinical Implications

Circulation

JANUARY 15, 2024

Nevertheless, the relationship between CAC and the susceptibility of a plaque to provoke a thrombotic event remains incompletely understood. This review summarizes the current understanding and literature on CAC.

Coronary Artery Disease

Coronary Artery Disease Atherosclerosis Laboratory Plaque

Who Needs a CT Coronary Angiogram?

All About Cardiovascular System and Disorders

APRIL 17, 2024

Conventional coronary angiograms are obtained by injecting medications directly into the coronary arteries and imaging them with X-ray equipment in cardiac catheterization laboratory. But it may not be that useful just to screen for blocks or build-up of plaques in those without any symptoms.

Coronary Angiogram

Coronary Angiogram Catheterization Laboratory Angioplasty Chest Pain

Abstract 4146638: Comparative Assessment of hsCRP and Apolipoprotein B as ASCVD Risk Biomarkers

Circulation

NOVEMBER 11, 2024

Introduction/Background:According to the American Heart Association, the accumulation of plaque in the walls of arteries is identified as the primary cause of atherosclerotic cardiovascular disease (ASCVD). Circulation, Volume 150, Issue Suppl_1 , Page A4146638-A4146638, November 12, 2024.

Biomarkers

Biomarkers Cardiovascular Disease Laboratory Plaque

Critical Left Main

EMS 12-Lead

JULY 24, 2023

Category 1 : Sudden narrowing of a coronary artery due to ACS (plaque rupture with thrombosis and/or downstream showering of platelet-fibrin aggregates. elevated BP), but rather directly correlated with coronary obstruction (due to plaque rupture and thrombosis) and, potentially, stymied TIMI flow. This results in Type I MI.

Angina

Angina Ischemia Coronary Angiogram Stenosis

Patient-specific in silico 3D coronary model in cardiac catheterisation laboratories

Frontiers in Cardiovascular Medicine

JULY 5, 2024

Coronary artery disease is caused by the buildup of atherosclerotic plaque in the coronary arteries, affecting the blood supply to the heart, one of the leading causes of death around the world. This paper explores the challenges and future directions associated with applying patient-specific in silico models in catheterisation laboratories.

Laboratory

Laboratory Coronary Artery Disease Interventional Cardiology Plaque

Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability

Circulation: Cardiovascular Imaging

FEBRUARY 19, 2024

BACKGROUND:It is not known whether there is a sex difference in the association between perivascular inflammation and plaque vulnerability. All images were analyzed at a core laboratory. plaques per patient) and 784 lesions in 327 men (2.4 plaques per patient). plaques per patient) and 784 lesions in 327 men (2.4

Plaque

Plaque Coronary Artery Disease Laboratory Cardiovascular Imaging

Micro and Nanoplastics and Cardiovascular Events – Recent Study

All About Cardiovascular System and Disorders

MARCH 7, 2024

Detailed analysis of the excised carotid plaques were carried out with pyrolysis-gas chromatography-mass spectrometry, stable isotope analysis, and electron microscopy. Primary endpoint of the study was a composite of myocardial infarction, stroke, or death from any cause in those who had micro and nanoplastics in the carotid plaque.

Plaque

Plaque Myocardial Infarction Laboratory Cardiac Function

Physiology Friday #232: Higher Aerobic Fitness Protects Against Declines in Brain Myelination

Physiologically Speaking

AUGUST 23, 2024

Some research suggests that myelin breakdown may even precede the formation of amyloid plaques, one of the hallmark features of Alzheimer’s, indicating that myelin damage could be an early event in the disease's progression. The deterioration of myelin with age is closely associated with cognitive decline. 1 Let’s dive in.

Physiology

Physiology Exercise Laboratory Dementia

Abstract TP288: Prevalence and Gender Differences in Carotid Atherosclerosis Among Adults: Evidence from a Cohort Study in China

Stroke Journal

JANUARY 30, 2025

Residents aged 18 years or older in the sampled areas were included in this study, and data were collected through questionnaires, physical examinations, laboratory tests, carotid ultrasound examinations, and biological sample collection. A consent information platform for data collection and quality control management was also developed.

Atherosclerosis

Atherosclerosis Plaque Stenosis Cardiovascular Disease

Normal ACS care, everything by the book! But normal ACS care could be much better. This post explains everything.

Dr. Smith's ECG Blog

MARCH 17, 2025

The patient was given aspirin 325 mg and laboratory workup was initiated. Nevertheless, the operator performed intravascular ultrasound and saw erupted calcium nodule consistent with plaque erosion. Initial high sensitivity troponin I (hsTnI) was 41 ng/L (reference: 35 ng/L). Echocardiogram showed inferior hypokinesis.

STEMI

STEMI Chest Pain Myocardial Infarction Document

Impact of Deucravacitinib on Plaque Psoriasis Treatment Landscape

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Roche's Lp(a) Gen.2 Molarity Assay Receives FDA Clearance

Webinars

Coronary Artery Calcification: Current Concepts and Clinical Implications

Who Needs a CT Coronary Angiogram?

Abstract 4146638: Comparative Assessment of hsCRP and Apolipoprotein B as ASCVD Risk Biomarkers

Critical Left Main

Patient-specific in silico 3D coronary model in cardiac catheterisation laboratories

Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability

Micro and Nanoplastics and Cardiovascular Events – Recent Study

Physiology Friday #232: Higher Aerobic Fitness Protects Against Declines in Brain Myelination

Abstract TP288: Prevalence and Gender Differences in Carotid Atherosclerosis Among Adults: Evidence from a Cohort Study in China

Normal ACS care, everything by the book! But normal ACS care could be much better. This post explains everything.

Stay Connected